Joshua S Boger bought $3.0M of CRVO
director, owner at CervoMed Inc.. 955,414 shares at an average of $3.14, traded Jun 11, 2026, filed Jun 15, 2026.
Score components
- +15RoleDirector
- +25Trade size$3.0M at market
- +10Relative to holdingsHoldings up 114%
- +18Price context8% above the 52-week low; 77% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-020691, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | POpen-market purchase Common Stockindirect: By Trusts | +955,414 | $3.14 | $3.0M | 1,795,865 | Jun 15, 2026 |
| Jun 11, 2026 | POpen-market purchase Series B Warrantsderivativeindirect: By Trust | +955,414 | - | - | 955,414 | Jun 15, 2026 |
| Jun 11, 2026 | POpen-market purchase Series C Warrantsderivativeindirect: By Trust | +955,414 | - | - | 955,414 | Jun 15, 2026 |
Related signals
Other insiders at CervoMed Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | CervoMed Inc. | John J Alam CEO & President | $183k 21,600 shares | +1% | |
| 53Moderate | CervoMed Inc. | William Robert Elder CFO, GC & Secretary | $29k 3,500 shares | +39% | |
| 47Moderate | CervoMed Inc. | Sylvie Gregoire director, owner | $183k 21,600 shares | +1% | |
| 51Moderate | CervoMed Inc. | Matthew Winton Chief Commercial and Business | $41k 5,000 shares | +50% | |
| 47Moderate | CervoMed Inc. | John J Alam CEO & President | $59k 7,847 shares | +1% | |
| 46Moderate | CervoMed Inc. | Matthew Winton Chief Commercial and Business | $76k 10,000 shares | - | |
| 37Weak | CervoMed Inc. | Sylvie Gregoire director, owner | $59k 7,847 shares | +1% | |
| 41Moderate | CervoMed Inc. | John J Alam CEO & President | $41k 5,553 shares | +0% | |
| 52Moderate | CervoMed Inc. | William Robert Elder CFO, GC & Secretary | $26k 3,500 shares | +64% | |
| 31Weak | CervoMed Inc. | Sylvie Gregoire director, owner | $41k 5,553 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.